Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marteus, H
Right arrow Articles by Alving, K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marteus, H
Right arrow Articles by Alving, K
Thorax 2005;60:219-225
© 2005 BMJ Publishing Group Ltd & British Thoracic Society


EXHALED MARKERS

Origin of nitrite and nitrate in nasal and exhaled breath condensate and relation to nitric oxide formation

H Marteus1, D C Törnberg2, E Weitzberg2, U Schedin3, K Alving1

1 Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden
2 Department of Surgical Sciences, Karolinska Institutet, Stockholm, Sweden
3 Division of Anaesthesia and Intensive Care, Danderyd Hospital, Stockholm, Sweden

Correspondence to:
Correspondence to:
Professor K Alving
Department of Physiology and Pharmacology, Karolinska Institutet, SE-171 77 Stockholm, Sweden; kjell.alving{at}fyfa.ki.se

Background: Raised concentrations of nitrate and nitrite have been found in exhaled breath condensate (EBC) in airway disease, and it has been postulated that this reflects increased nitric oxide (NO) metabolism. However, the chemical and anatomical origin of nitrate and nitrite in the airways has not yet been sufficiently studied.

Methods: The fraction of exhaled NO at an exhalation flow rate of 50 ml/s (FENO) and nitrite and nitrate in EBC, nasal condensate, and saliva were measured in 17 tracheostomised and 15 non-tracheostomised subjects, all of whom were non-smokers without respiratory disease. Tracheal and oral samples were taken from the tracheostomised subjects and nasal (during velum closure) and oral samples from the non-tracheostomised subjects. Measurements were performed before and after sodium nitrate ingestion (10 mg/kg) and use of antibacterial mouthwash (chlorhexidine 0.2%).

Results: In tracheostomised subjects oral FENO increased by 90% (p<0.01) while tracheal FENO was not affected 60 minutes after nitrate ingestion. Oral EBC nitrite levels were increased 23-fold at 60 minutes (p<0.001) whereas the nitrite levels in tracheal EBC showed only a minor increase (fourfold, p<0.05). Nitrate was increased the same amount in oral and tracheal EBC at 60 minutes (2.5-fold, p<0.05). In non-tracheostomised subjects oral FENO and EBC nitrite increased after nitrate ingestion and after chlorhexidine mouthwash they approached baseline levels again (p<0.001). Nasal NO, nitrate, and nitrite were not affected by nitrate intake or mouthwash. At baseline, mouthwash with deionised water did not affect nitrite in oral EBC or saliva, whereas significant reductions were seen after antibacterial mouthwash (p<0.05 and p<0.001, respectively).

Conclusions: Besides the salivary glands, plasma nitrate is taken up by the lower airways but not the nasal airways. Nitrate levels in EBC are thus influenced by dietary intake. Nitrate is reduced to nitrite by bacterial activity which takes place primarily in the oropharyngeal tract of healthy subjects. Only oropharyngeal nitrite seems to contribute to exhaled NO in non-inflamed airways, and there is also a substantial contribution of nitrite from the oropharyngeal tract during standard collection of EBC.


Abbreviations: EBC, exhaled breath condensate; FENO, fraction of expired nitric oxide; CF, cystic fibrosis; PCD, primary ciliary dyskinesia; NO, nitric oxide; dH2O, deionised water

Keywords: exhaled nitric oxide; exhaled breath condensate; nitrite; nitrate




This article has been cited by other articles:


Home page
Eur Respir JHome page
Z. L. Borrill, K. Roy, and D. Singh
Exhaled breath condensate biomarkers in COPD
Eur. Respir. J., August 1, 2008; 32(2): 472 - 486.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. S. Jackson, A. Sandrini, C. Campbell, S. Chow, P. S. Thomas, and D. H. Yates
Comparison of Biomarkers in Exhaled Breath Condensate and Bronchoalveolar Lavage
Am. J. Respir. Crit. Care Med., February 1, 2007; 175(3): 222 - 227.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
F. Gaber, F. Acevedo, I. Delin, B-M. Sundblad, L. Palmberg, K. Larsson, M. Kumlin, and S-E. Dahlen
Saliva is one likely source of leukotriene B4 in exhaled breath condensate
Eur. Respir. J., December 1, 2006; 28(6): 1229 - 1235.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
I. Horvath, J. Hunt, P. J. Barnes, and On behalf of the ATS/ERS Task Force on Exhaled Bre
Exhaled breath condensate: methodological recommendations and unresolved questions
Eur. Respir. J., September 1, 2005; 26(3): 523 - 548.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
I Horvath
The exhaled biomarker puzzle: bacteria play their card in the exhaled nitric oxide-exhaled breath condensate nitrite game
Thorax, March 1, 2005; 60(3): 179 - 180.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 BMJ Publishing Group Ltd & British Thoracic Society